BMSEED Accepted to 2019/2020 NIH Commercialization Accelerator Program (CAP)

Programs
Written By Cami Rowan
 
 

BMSEED was accepted to the 2019/2020 cohort of the NIH Commercialization Accelerator Program (CAP). The nationwide NIH CAP program aims to assist the most promising small life science and healthcare companies in bringing their technologies to market. BMSEED is one of 80 selected applicants that will have access to domain expertise and industry connections. The 2019/2020 program kicks off Sept 2019 and ends June 2020.

Cami Rowan
Previous

BMSEED Accepted as Finalist in 2020 Venture Madness
Next

BMSEED Presenting at 2019 Neurotrauma Meeting